Fragile X deficits in mice respond to gene therapy
Researchers at the University of California, Riverside have successfully used gene therapy to restore brain activity and improve behavior in mice with Fragile X syndrome. By delivering a healthy version of the FMR1 gene, the treatment addressed the underlying protein deficiency that causes the neurodevelopmental disorder.
Why it matters
This study offers a potential path toward treating the root cause of Fragile X syndrome, a leading genetic cause of autism, rather than just managing symptoms.
by Iqbal Pittalwala, University of California - Riverside
The article reports on scientific findings using neutral, evidence-based language without political or social framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in